Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Mechanistic pharmacodynamic models that incorporate the binding kinetics of drug-target interactions have several advantages in understanding target engagement and the efficacy of a drug dose. However, guidelines on how to build and interpret mechanistic pharmacodynamic drug-target binding models considering both biological and computational factors are still missing in the literature. In this chapter, current approaches of building mechanistic PD models and their advantages are discussed. We also present a methodology on how to select a suitable model considering both biological and computational perspectives, as well as summarize the challenges of current mechanistic PD models. © 2022. Springer Science+Business Media, LLC, part of Springer Nature.


Jingyi Liang, Vi Ngoc-Nha Tran, Colin Hemez, Pia Abel Zur Wiesch. Current Approaches of Building Mechanistic Pharmacodynamic Drug-Target Binding Models. Methods in molecular biology (Clifton, N.J.). 2022;2385:1-17

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 34888713

View Full Text